ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Levicept Ltd

Levicept Ltd is an active company incorporated on 23 August 2012 with the registered office located in Sandwich, Kent. Levicept Ltd was registered 13 years ago.
Status
Active
Active since incorporation
Company No
08190142
Private limited company
Age
13 years
Incorporated 23 August 2012
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 26 January 2025 (7 months ago)
Next confirmation dated 26 January 2026
Due by 9 February 2026 (5 months remaining)
Last change occurred 7 months ago
Accounts
Submitted
For period 1 Oct31 Dec 2024 (1 year 3 months)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (1 year remaining)
Contact
Address
Office 20, Second Floor Innovation House
Ramsgate Road
Sandwich
Kent
CT13 9FF
United Kingdom
Same address for the past 9 years
Telephone
Unreported
Email
Unreported
People
Officers
6
Shareholders
10
Controllers (PSC)
1
Director • British • Lives in UK • Born in Aug 1960
Director • Investor • Italian • Lives in Switzerland • Born in Jan 1970
Director • Investment Manager • Dutch • Lives in Netherlands • Born in Jun 1976
Director • Chief Immunology Officer • Dutch • Lives in UK • Born in Dec 1959
Director • Venture Capital • British • Lives in UK • Born in Jul 1960
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Parekh Enterprises Limited
Dr Rajesh Bhikhu Parekh is a mutual person.
Active
Crescendo Biologics Limited
Dr Kevin Stuart Johnson is a mutual person.
Active
Advent LS Services Limited
Dr Rajesh Bhikhu Parekh is a mutual person.
Active
Kaerus Bioscience Limited
Francesco De Rubertis is a mutual person.
Active
Ottimo Pharma Limited
Francesco De Rubertis is a mutual person.
Active
Inhibitaxin Limited
Dr Kevin Stuart Johnson is a mutual person.
Dissolved
Ultrahuman One Limited
Francesco De Rubertis is a mutual person.
Dissolved
Ultrahuman Thirteen Limited
Francesco De Rubertis is a mutual person.
Liquidation
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 1 Oct31 Dec 2024
Traded for 15 months
Cash in Bank
£3.46M
Increased by £2.94M (+563%)
Turnover
Unreported
Same as previous period
Employees
9
Same as previous period
Total Assets
£4.45M
Decreased by £1.4M (-24%)
Total Liabilities
-£21.81M
Decreased by £2.39M (-10%)
Net Assets
-£17.36M
Increased by £986K (-5%)
Debt Ratio (%)
490%
Increased by 76.68% (+19%)
Latest Activity
Small Accounts Submitted
4 Months Ago on 14 Apr 2025
Confirmation Submitted
7 Months Ago on 27 Jan 2025
Accounting Period Extended
7 Months Ago on 16 Jan 2025
Small Accounts Submitted
1 Year 2 Months Ago on 24 Jun 2024
Confirmation Submitted
1 Year 7 Months Ago on 29 Jan 2024
Mr Eliot Richard Forster Appointed
1 Year 9 Months Ago on 1 Dec 2023
Simon Lempriere Westbrook Resigned
1 Year 9 Months Ago on 1 Dec 2023
Small Accounts Submitted
2 Years 2 Months Ago on 30 Jun 2023
Confirmation Submitted
2 Years 6 Months Ago on 16 Feb 2023
Small Accounts Submitted
2 Years 11 Months Ago on 29 Sep 2022
Get Credit Report
Discover Levicept Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Accounts for a small company made up to 31 December 2024
Submitted on 14 Apr 2025
Confirmation statement made on 26 January 2025 with updates
Submitted on 27 Jan 2025
Previous accounting period extended from 30 September 2024 to 31 December 2024
Submitted on 16 Jan 2025
Accounts for a small company made up to 30 September 2023
Submitted on 24 Jun 2024
Statement of capital following an allotment of shares on 5 April 2024
Submitted on 19 Apr 2024
Statement of capital following an allotment of shares on 5 April 2024
Submitted on 18 Apr 2024
Confirmation statement made on 26 January 2024 with updates
Submitted on 29 Jan 2024
Statement of capital following an allotment of shares on 5 January 2024
Submitted on 23 Jan 2024
Statement of capital following an allotment of shares on 5 January 2024
Submitted on 23 Jan 2024
Termination of appointment of Simon Lempriere Westbrook as a director on 1 December 2023
Submitted on 9 Jan 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year